Literature DB >> 11129662

Differential chemokine response of human monocytes to yeast and hyphal forms of Candida albicans and its relation to the beta-1,6 glucan of the fungal cell wall.

A Torosantucci1, P Chiani, A Cassone.   

Abstract

Hyphae formation from yeast cells is a virulence trait enabling the human opportunistic pathogen Candida albicans to invade host tissues. Hyphal cells proved to be much less efficient than yeast cells in stimulating production of macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, interleukin-8 (IL-8), and particularly, monocyte chemotactic protein-1 (MCP-1) by human monocyte. This different stimulation did not depend on the monocyte inability to ingest the hyphae nor did it imply hyphal resistance to the extracellular killing by the monocytes. Purified hyphal and yeast cell walls reproduced the differences shown by the intact cells, and chemical-enzymatic dissection of cell wall components suggested that cell wall beta-1,6 rather than beta-1,3 glucan was the main chemokine inducer. Coherently, immunofluorescence studies with an anti beta-1,6 glucan serum showed that the surface expression of this polysaccharide was much lower on hyphae than on yeast cells. By minimizing chemokine induction, the formation of hyphal filaments might facilitate C. albicans escaping from host immunity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11129662

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  24 in total

1.  Induction of interleukin-12 and gamma interferon requires tumor necrosis factor alpha for protective T1-cell-mediated immunity to pulmonary Cryptococcus neoformans infection.

Authors:  Amy C Herring; John Lee; Roderick A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

2.  C. albicans increases cell wall mannoprotein, but not mannan, in response to blood, serum and cultivation at physiological temperature.

Authors:  Michael Kruppa; Rachel R Greene; Ilka Noss; Douglas W Lowman; David L Williams
Journal:  Glycobiology       Date:  2011-04-21       Impact factor: 4.313

Review 3.  Anticandidal immunity and vaginitis: novel opportunities for immune intervention.

Authors:  Antonio Cassone; Flavia De Bernardis; Giorgio Santoni
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

4.  Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans.

Authors:  Hee Sup Kim; Eun Hwa Choi; Javed Khan; Emmanuel Roilides; Andrea Francesconi; Miki Kasai; Tin Sein; Robert L Schaufele; Kenichi Sakurai; Chang Gue Son; Braden T Greer; Stephen Chanock; Caron A Lyman; Thomas J Walsh
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

5.  An anti-inflammatory property of Candida albicans β-glucan: Induction of high levels of interleukin-1 receptor antagonist via a Dectin-1/CR3 independent mechanism.

Authors:  Sanne P Smeekens; Mark S Gresnigt; Katharina L Becker; Shih-Chin Cheng; Stejara A Netea; Liesbeth Jacobs; Trees Jansen; Frank L van de Veerdonk; David L Williams; Leo A B Joosten; Charles A Dinarello; Mihai G Netea
Journal:  Cytokine       Date:  2014-11-20       Impact factor: 3.861

6.  Contribution of Candida albicans cell wall components to recognition by and escape from murine macrophages.

Authors:  C G J McKenzie; U Koser; L E Lewis; J M Bain; H M Mora-Montes; R N Barker; N A R Gow; L P Erwig
Journal:  Infect Immun       Date:  2010-02-01       Impact factor: 3.441

Review 7.  Surface glycans of Candida albicans and other pathogenic fungi: physiological roles, clinical uses, and experimental challenges.

Authors:  James Masuoka
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Immunomodulatory and protective effects of moxifloxacin against Candida albicans-induced bronchopneumonia in mice injected with cyclophosphamide.

Authors:  Itamar Shalit; Limor Horev-Azaria; Ina Fabian; Hannah Blau; Naam Kariv; Itsak Shechtman; Hannah Alteraz; Yehudith Kletter
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

9.  Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis.

Authors:  Luciano Polonelli; Walter Magliani; Stefania Conti; Luisa Bracci; Luisa Lozzi; Paolo Neri; Daniela Adriani; Flavia De Bernardis; Antonio Cassone
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

10.  Candida albicans yeast and germ tube forms interfere differently with human monocyte differentiation into dendritic cells: a novel dimorphism-dependent mechanism to escape the host's immune response.

Authors:  Antonella Torosantucci; Giulia Romagnoli; Paola Chiani; Annarita Stringaro; Pasqualina Crateri; Sabrina Mariotti; Raffaela Teloni; Giuseppe Arancia; Antonio Cassone; Roberto Nisini
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.